Clinical Trial Update: Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and efficacy of CLT-008 human myeloid progenitor cells during chemotherapy in acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Neutropenia

Drugs mentioned

• CLT-008 (human myeloid progenitor cells)

Snippet

Sponsor: Cellerant Therapeutics | Conditions: Acute Myeloid Leukemia, Neutropenia | Phase 2 | Status: COMPLETED